LINE-1 as a Therapeutic Target for Castration-Resistant Prostate Cancer

Frontiers in Bioscience - Landmark - United States
doi 10.2741/4644
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers in Bioscience

Related search

Targeting TCTP as a New Therapeutic Strategy in Castration-Resistant Prostate Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Emerging Role of Glucocorticoid Receptor in Castration Resistant Prostate Cancer: A Potential Therapeutic Target

Journal of Cancer
Oncology
2020English

Pirin: A Potential Novel Therapeutic Target for Castration-Resistant Prostate Cancer Regulated by miR-455-5p

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

Increased Androgen Receptor Transcription: A Cause of Castration-Resistant Prostate Cancer and a Possible Therapeutic Target

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2011English

STAT3 and STAT5A Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer

Oncotarget
Oncology
2017English

Ailanthone: A New Potential Drug for Castration-Resistant Prostate Cancer

Chinese Journal of Cancer
2017English

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

HMGB1: A Promising Therapeutic Target for Prostate Cancer

Prostate Cancer
Cancer ResearchOncologyUrology
2013English

The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy